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Abstract
Depression, a sequela of stroke, is underrecognized and underreported. The American
Heart/Stroke Association estimated 1/3 of patients develop depression after a stroke.
Depression after a stroke has negative influence on stroke recovery through decreased
participation in rehabilitation, and increased morbidity and mortality. The American
Heart/Stroke Association recommended that depression screening be conducted on stroke
patient; however, there is a lack of guidance regarding the optimal time and tools for
depression screening. The practice problem identified was the absence of depression
screening in poststroke patients at the project site. The project question focused on
identifying evidence-based approaches for depression screening in poststroke patients.
The goal of the project was to develop clinical practice guidelines for depression
screening poststroke. The framework used to develop the project was the John Hopkins
Evidence-Based Nursing model. An expert panel was used to evaluate the developed
clinical practice guidelines. Serving as participants, expert panelist were selected based
on their background in stroke care management. Panelists evaluated the guidelines using
the Appraisal of Guidelines for Research and Evaluation Instrument II standard
instrument tool. Twenty-five percent of reviewers recommended using the guidelines and
75% recommended using the guidelines with minor modifications. Implementation of
clinical practice guidelines support depression screening after stroke leading to increased
awareness, education, recognition and reporting. The findings of this project have the
potential for positive social changes by improving depression screening in stroke patients
and increasing early recognition and reporting of depression poststroke.
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Section 1: Nature of the Project
Introduction
Depression in the poststroke patient has been documented in the literature as
having a negative impact in clinical outcomes (Jia et al., 2010). The occurrence and
impact of depression may vary depending on the severity of disability and location of
cerebral infarct (Kouwenhoven, Kirkevold, Engedal, & Kim, 2011). Depression in
poststroke patients can lead to fatigue, pain, and failure to participate in rehabilitation
activities (Lerdal et al., 2011). Stroke is the leading cause of disability in the United
States, with 20% of people requiring institutional care 3 months poststroke (Hollender,
2014). It has been estimated that approximately one third of stroke patients will be
affected by depression (Hollender, 2014). Kouwenhoven, Kirkevold, Engedal, and Kim,
(2011), stated that the incidence of poststroke depression is higher within 1-month post
stroke than later phases.
Stroke is the leading cause of disability, which can result in life changing
alterations for the stroke survivor. Depending on the severity of the stroke, the survivor
may have limitations on the degree of independence, subsequently affecting their quality
of life and participation in the life known before the stroke (Kouwenhoven, Kirkevold,
Engedal, & Kim, 2012). Although the survivor is alive, it can be assumed there is a
perception of loss. Poststroke depression is associated with physical disability, stroke
severity, history of depression, and cognitive impairment (American Heart Association
Stroke Council, 2017). Additionally, poststroke depression is attributed to poorer
functional outcome (American Heart Association Stroke Council, 2017). The American
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Heart Association Stroke Council, (2017) stated that one in three stroke survivors suffers
from depressive symptoms because of biological and psychosocial factors. However, in
lieu of the prevalence of poststroke depression, there is no standard or guidelines for
screening of depressive symptoms in this population.
This evidence-based project relates to the Doctor of Nursing Practice (DNP)
Essential II: Organizational and Systems Leadership for Quality Improvement and
Systems Thinking, with emphases on the DNP students’ leadership roles in recognizing
health care issues and use of evidence-based knowledge to improve patient health
outcomes (American Association of Colleges of Nursing [AACN], 2006). The AACN
(2006) further detailed DNP Essential III: Clinical Scholarship and Analytical Methods
for Evidence-Based Practice, which focuses on the DNP students’ ability to interpret,
spread, and assimilate research into evidence-based practice. Implementation of
evidence-based practice is not an uncommon occurrence within the acute care setting.
However, when existing guidelines neglect to include hospital organizations,
subsequently the discussion changes to “is this guideline best practice and should the
organization adopt it?” According to Campos (2011), evidence-based practices are
interventions or programs that have been rigorously scientifically evaluated for
effectiveness, whereas best practice lack independent evaluation of effectiveness.
The nature of the DNP project was to develop a clinical practice guideline based
on the evidence to facilitate a process for depression screening in poststroke patients,
ultimately leading the organization to implement the guideline. An additional implication
of the DNP project was to impact social change through adoption of the guideline across
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the system and into the clinical setting. An additional impact for social change included
presentation of clinical guidelines at various conferences and meetings as appropriate.
Problem Statement
The problem that was addressed in the evidenced-based project is the lack of
depression screening in the poststroke patient as evidenced by non existing tools, policies
or procedures. While recent reports indicate over 1,500 patients have been treated for
stroke at the project site, data on how many of those patients have reported symptoms
related to depression is unknown. In a recent statement by the American Heart
Association Stroke Council (2017), depression affects one third of stroke survivors and is
associated with poor functional outcomes and increase mortality. Most patients,
approximately half of stroke survivors, are discharged home with persistent neurological
impairments (Andersen et al., 2000). Readmission rates within 1 year of stroke range
from 20% to 27% (Andersen et al., 2000). Increase health care costs and emotional
distress are associated with readmission of the stroke patient, a common occurrence in the
acute care setting (Andersen et al., 2000).
The Joint Commission standards for primary stroke center details essential
requirements for the stroke program. In the disease specific requirements chapter titled
Delivering or Facilitating Clinical Care, (DSDF) Element 4 provides specific
requirements to address the plan of care that is based on a needs assessment (The Joint
Commission, 2017). In comparing the DSDF Element 4 in a Primary Stroke Center, a
similar standard with the Comprehensive Stroke Center requirements, indicates that there
is a notable difference. In the comprehensive center requirement, there is an element for
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assessing the patient for depression, cognitive decline, and other social issues prior to
discharge (The Joint Commission, 2017), however the primary stroke center standards do
not have this as a requirement. Recently, the standards for a comprehensive certified
center have been updated, eliminating the requirement for depression screening (The
Joint Commission, 2018). Prior to this recent update, this difference led to variation in
practice in the delivery of patient care and potential outcomes among the stroke patients
treated in a primary stroke center versus a comprehensive stroke center.
The stroke population characteristics between a primary care center and a
comprehensive care center are relatively the same with the major difference being
available intervention options. Although there is not a consistent standard between the
primary center certification and the comprehensive center certification regarding
depression screening, there is a recommendation by the U.S. Preventive Services Task
Force (USPSTF) for depression screening in all adult patients.
The number of stroke survivors will likely increase because of the improvements
in the management of acute strokes (Lightbody et al., 2007). Subsequently, this leads to
an increase number of individuals living with a disability either physically or cognitively
(Lightbody et al., 2007). Nursing practice has long held an interest in improving patient
outcomes and nurses possess the skills to assess factors that will have a negative impact
on them. Nursing can play an active role in recognition and management of poststroke
depression, a common consequence of a stroke (Lightbody et al., 2007; Melrose, 2016),
through engagement in early depression screening.
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Purpose
The primary aim of this DNP project was to develop a clinical practice guideline
for depression screening in the poststroke patient. A clinical practice guideline can be
defined as statements that include recommendations intended to optimize patient care that
are informed by a systematic review of evidence and an assessment of the benefits and
harms of alternative care options (Rosenfeld & Shiffman, 2009).
The evidence is clear that poststroke patients have an increase propensity of
developing depression, subsequently leading to poorer outcomes, decreased quality of
life, increase readmission rates, and increase mortality (American Heart Association
Stroke Council, 2017; Andersen et al., 2000; Robinson-Smith, Johnston, & Allen, 2000;
Whyte & Mulsant, 2002). The opportunity between the recommendation of the evidence
and current practice, can be lessened with a clinical practice guideline for depression
screening in post stroke patients.
Nature of the Doctorate Project
The nature of this project involved development of a clinical practice guideline
for depression screening. I used the John Hopkins Nursing Evidence-Based Practice
model (JHNEBP) (Newhouse, John Hopkins University, Sigma Theta Tua International,
& John Hopkins Hospital, 2007). The model described in detail later, consist of three
phases. Using the JHNEBP model, the first phase identified absence of a clinical practice
guideline to facilitate depression screening in poststroke patients as the practice problem.
In accordance with the second phase of the JHNEBP model, my next step was to review
the research and non research available for depression in poststroke patients. Sources of
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evidence that I considered included original research papers, journal articles, organization
recommendations, questionnaires, other evidence-based projects and systematic reviews.
The final phase, translation, is where the feasibility of use of the clinical practice
guideline will be evaluated with consideration of the external and internal factors (see
Newhouse, John Hopkins University, Sigma Theta Tua International, & John Hopkins
Hospital, 2007) Also, in the last phase, the evaluation of the guideline was collected,
analyzed and disseminated to the stakeholders of the organization.
The evidence-based project involved several actions. First, I used JHNEBP to
facilitate a review of the evidence and evaluate internal and external factors as it related
to the development of the clinical practice guideline (see Newhouse, John Hopkins
University, Sigma Theta Tua International, & John Hopkins Hospital, 2007). Second, the
literature was critically appraised, then synthesized. Following a synthesis of the
literature, the clinical practice guideline was developed. Nearing the completion of the
guideline, I identified members for expert panel review to provide anonymous feedback
of the clinical guideline using the AGREE II instrument. I revised the guidelines based on
the recommendations of the expert panel. At the end of completing the revision, another
group was formed consisting of key stakeholders and end users. The purpose of the
second group was to discuss usability and validate content. The final steps of the process
were to develop a final report and disseminate to key stakeholders.
Significance of the Project
Poststroke depression has a significant impact on the recovery of stroke survivors
(Robinson-Smith et al., 2000). Despite the negative impact, there lacks a specific
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guideline or protocol on when or how to screen for depression in poststroke patients.
Although the USPSTF has recommended depression for all adults, it currently excludes
settings such as hospitals or other acute care settings. In the DNP project setting key
stakeholders included the stroke coordinator, the stroke program medical director, chief
nursing officer, unit director of the primary stroke unit, unit leadership, and staff nurses.
Nurses in the acute phase have the potential to significantly impact outcomes for the
poststroke patient through identifying patients at risk for poststroke depression because of
their proximity and education efforts across the continuum (Babkair, 2017; Klinedinst,
Dunbar, & Clark, 2012; Stanfill, Elijovich, Baughman, & Conley, 2016). Because of the
unique position of nursing in patient and family education, care givers and poststroke
patients will have increased awareness of depressive signs. Consequentially, increasing
the recognition and reporting of depressive signs in the poststroke patient has the
likelihood of prompt treatment and lessen the stigma of depression (Klinedinst et al.,
2012). Early identification and treatment of depression in poststroke patients can have a
positive impact on participation in rehabilitation and quality of life.
Through the development of a clinical guideline, I hoped to increase awareness of
poststroke depression while simultaneously facilitating a standardized approach to
depression screening across the healthcare system. Dissemination of the clinical practice
guideline at local and regional conferences would broaden the social impact to other
organizations seeking to implement a similar practice.
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Summary
Section 1 provided an overview of poststroke depression, impact of depression in
poststroke patients, and current guidelines from the USPSTF. The practice problem that
the DNP project addressed is development of a clinical practice guideline for depression
screening in poststroke patients. The goal of this project was to develop an evidencebased clinical practice guideline that facilitated screening in poststroke patients, a highrisk group for depression. In the next section the background and context of depression in
poststroke patients will be further explained.
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Section 2: Background and Context
Introduction
The purpose of this DNP project was to develop a clinical practice guideline for
depression screening in poststroke patients that include the following scope, purpose, and
recommendations for depression screening. The goal of this project was to provide the
clinical site with a clinical practice guideline that supports depression screening in
poststroke patients. In this section concepts, relevance to nursing practice, local
background and context, and the role of the DNP student are discussed.
Concepts, Models and Theories
For this project, I used the JHNEBP. The JHNEBP model is composed of three
phases including practice, evidence, and translation (PET) (Newhouse et al., 2007). Phase
1 consists of recognizing and identifying a practice problem to answer (Newhouse et al.,
2007). In this DNP project, the problem was the absence of a clinical practice guideline
for depression screening in the poststroke patient. The second phase involved a
comprehensive review of synthesis of research and non research evidence on the topic of
the post stroke patient for depression. Lastly, the final phase was the implementation of
the proposed change as a pilot study, in this instance a DNP project, measure outcomes,
and dissemination of findings. The last phase of the JHNEBP model was demonstrated as
evident by synthesis of the evidence to develop the guideline, review and validation from
an expert panel, end user and stakeholder feedback, creation of a final report, and
dissemination of the clinical guideline for recommendations. Other concepts of the model
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are the influence of internal and external factors in implementation of the proposed
change (see Newhouse et al., 2007).
This model is an open system that consist of several related components. The
outputs from the JHNEBP are influenced by internal and external factors (see Newhouse
et al., 2007). The model, which is a process that facilitates translating evidence into
practice, steps include identifying the evidence-based practice question, researching the
evidence, and translation of evidence into practice (see Newhouse et al., 2007). However,
within each major element there are several steps that occur as one matriculates through
the process. This model has been used extensively by nurses to implement practice
changes on infection prevention programs, postoperative urinary retention, and alarm
fatigue (Buchko & Robinson, 2012; Dillman, Mancas, Jacoby, & Ruth-Sahd, 2014; Mori,
2015).
Mori (2015) conducted a quality improvement project to improve outcomes in
orthopedic patients undergoing total knee arthroplasty by implementation of evidencebased practice guidelines to prevent surgical site infections. The JHNEBP model was
used to implement an infection prevention program. The project used guideline
recommendations from the Institute of Healthcare Improvement (IHI) on prevention of
surgical site infections. The population involved included patients undergoing total hip
arthroplasty (THA) and total knee arthroplasty (TKA). Based on the recommendations in
the evidence, each THA and TKA patient would receive nasal swab testing for
Methicillin-sensitive Staphylococcus aureus (MSSA) and Methicillin-resistant
Staphylococcus aureus (MRSA) 2 weeks prior to surgery, a bath containing
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Chlorhexidine Gluconate (CHG) was administered 5 days prior to surgery, the day before
surgery and the morning of surgery, to decolonize patients who had a positive MSSA or
MRSA swab test result. An additional process was implemented for those patients with
negative results for MSSA or MRSA to receive decolonization timely prior to surgery
(Mori, 2015). Implementing the evidence-based guidelines resulted in reduction in
surgical site infections, from 5.3% prior to implementation of the evidence-based project
to 0% 7 months after implementation (Mori, 2015).
Buchko and Robinson (2012) conducted a project in a 43-bed adult postpartum
gynecologic unit in a community teaching hospital studying women who recently
underwent urogynecology surgery with postoperative urinary retention. The purpose of
the project was to identify evidence and management for postoperative urinary retention
in women who had urogynecology surgery and integrate it into an evidence-based
protocol. Buchko and Robinson described how the JHNEBP model was used to facilitate
development of an evidence-based algorithm to use in a pilot study to evaluate
effectiveness of the postoperative urinary retention algorithm.
Dillman, Mancas, Jacob, and Ruth-Sahd (2014) described a systematic literature
review of patient outcomes in critically ill uninsured patients compared to the critically ill
insured patients. The authors described how the JHNEBP model was used to conduct the
literature review. After reviewing the literature in accordance with the model guidelines,
results showed poorer patients who are critically ill have worse outcomes if uninsured
(Dillman et al., 2014). Authors in the previously referenced studies demonstrated
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application of the JHNEBP model to conduct evidence-based research. As detailed below
evidence-based sources are a cornerstone in nursing research.
In an addition to using the JHNEBP model in my DNP project, I incorporated
evidence-based sources. Evidenced-based practice (EBP) is the careful incorporation of
the best research evidence with clinical expertise and patient values and needs in the
delivery of quality, cost effective health care (Grove, Burns, & Gray, 2013). EBP also
affords opportunities for nursing care to be individualized, effective, streamlined, active
and amplify effects of clinical judgement (Grove et al., 2013). Evidence-based protocols
facilitate early recognition and early interventions in conditions that have the potential of
negative consequences if not treated early. Cervical cancer, nutritional, breast cancer, and
colon cancer screenings have had a positive impact on early identification and treatment
of the respective diseases (Grove et al., 2013). Evidence-based sources are highly
perceived in healthcare. These sources serve as guide to change practice or implement
new process that will have a positive effect on the population.
Relevance to Nursing Practice
Depression has been demonstrated to be common in poststroke patients, occurring
as early as 2 weeks up to 1 year following a stroke (Buga, Filfan, George, & PopaWagner, 2015; Damush et al., 2008; Hermann et al., 2011; Hollender, 2014; Joubert et
al., 2006; Kouwenhoven, Kirkevold, Engedal, & Kim, 2012). Depression is associated
with poor functional outcomes and higher mortality rates in poststroke patients
(American Heart Association Stroke Council, 2017). Lack of a protocol supports the need
for clinical practice guidelines on how to assess for depression in the poststroke patient.

13
Adverse consequences of lack of screening include late recognition and identification of
depression in poststroke patients (Klinedinst et al., 2012). Additional outcomes due to
lack of standards for depression screening in the acute care setting in this population
contributes to under recognition of potential depressive signs and subsequently delayed
referral for treatment (Klinedinst et al., 2012). Depression after a stroke is relevant to
nursing practice because of the associated poor functional outcomes, high mortality rates,
and the lack of a standardize process for assessment of depressive symptoms.
The USPSTF is an independent group of national experts in prevention and
evidence-based medicine (US Department of Health & Human Services, 2012). This
panel of experts works to improve the health of all Americans by making evidence-based
recommendations about clinical preventive services such as screenings, counseling
services, or preventive medications (U.S. Department of Health & Human Services,
2012). In recent years, this agency has focused on recommendations addressing early
identification of depression (US Department of Health & Human Services, 2012). The
USPSTF recommends screening of all adult patients for depression regardless of risk
factors (Siu & U.S. Preventive Services Task Force, 2016). The recommendations are
based on substantial evidence that there are a variety of factors associated with
depression including persons with chronic illness, other mental disorders, advanced age,
disability, poor health status related to medical illness, complicated grief, chronic sleep
disturbances, loneliness, and a history of depression (Siu & U.S. Preventive Services
Task Force, 2016). However, within the acute care setting in the southern United States,
which this DNP project is intended, there is no established tool in accordance with the
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recommendations for depression screening. Considering that the USPSTF
recommendation includes all patients in the acute care setting, in conjunction with
recommendations from the American Stroke Association, I focused on a select high-risk
population, the poststroke patient.
Stroke is a common medical illness in the United States, affecting approximately
over 600,000 cases annually (American Heart Association, 2015). A person may suffer
major changes in their because of a stroke. Loss of health, occupation, social role, and
independence are some adverse effects of a stroke (Whyte & Mulsant, 2002). Poststroke
depression affects approximately a third of the stroke survivor population and is a
significant world health problem (Buga et al., 2015). Depression affects approximately
5.4 to 8.9% of nonstroke patients and accounts for more than $43 billion in medical care
costs within the United States (Maurer & Darnall, 2012). Maurer and Darnall (2012) also
reported that depression is projected to become the second largest cause of disability by
2020. Symptoms of depression can be specific as depressed mood, loss of interest in
activities, impaired concentration, feelings of guilt, and suicidal ideation, however the
symptoms can be nonspecific (Maurer & Darnall, 2012). Nonspecific symptoms include
abdominal pain, back pain, change in weight or appetite, constipation, fatigue, headache,
insomnia or hypersomnia, joint pain, neck pain and weakness (Maurer & Darnall, 2012).
Although symptoms of depression range from specific to nonspecific, there are risk
factors that would place an individual at a higher susceptibility for depression. Chronic
medical illness, chronic minor daily stress, chronic pain syndrome, family history of
depression, female gender, low income, job loss, low self-esteem, low social support,
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prior depression, single, divorced, widowed, traumatic brain injury, and younger are
associated with the prevalence of depression (Maurer & Darnall, 2012). The USPSTF has
made recommendation for recognition of general depression symptoms but within the
broad classification at risk patients, the stroke patient has a higher risk of depression.
Although generalized depressive symptoms include those referenced above,
poststroke depression presents as fatigue, insomnia and psychomotor impedance (Buga et
al., 2015). Buga et al. (2015) estimated that 30% of stroke survivors suffer from
poststroke depression, which affects short-term and long-term rehabilitation. Additional
consequences of poststroke depression include poor outcomes, delay in recovery,
impaired cognition, decreased quality of life, and decreased treatment efficiencies, as
well as having mortality rates three times higher when compared to those without
depression (Buga et al., 2015). According to Buga et al., 40% of poststroke patients will
have an onset of depression within 3 months after suffering from a stroke. In those
patients with a likelihood of developing depression, 30% develop depression after
hospital discharge (Buga et al., 2015). Consequently, poststroke patients who continue to
suffer from depression also exhibit failure to follow treatment plans and irritability with
personality changes (Buga et al., 2015). Although negative outcomes are associated with
depression in poststroke patients, there is little guidance on the optimal process to screen
poststroke patients regarding timing of conducting a depression screening. The primary
recommendation for depression screening comes from the USPSTF, which recommends
depression screening in all adults (Siu & U.S. Preventive Services Task Force, 2016).
However, the recommendations currently appear to be limited to the primary care setting,
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excluding acute care settings such as hospitals. Another limitation in the
recommendations is the reference that screening should be implemented in settings that
have adequate systems in place to provide accurate diagnosis, effective treatment and
appropriate follow-up (Siu & U.S. Preventive Services Task Force, 2016). Depression
after a stroke is a common sequela, despite the associated negative outcomes and
prevalence of depression following a stroke there is a lack guidance for detection and
reporting.
Depression is a condition with high prevalence worldwide. Depression includes
disorders of major depression, minor depression and dysthymia. Depression affects
approximately 340 million people worldwide, with 18 million people suffering from
depression in the United States (Egede & Ellis, 2010). Egede and Ellis (2010) reported
that according to the World Health Organization depression is accountable for the highest
proportion of burdens associated with non-fatal health outcomes accounting for
approximately 12% total years lived with disability. Studies have demonstrated that
depression is a major cause of morbidity, mortality and increased use of healthcare
resources (Andersen et al., 2000; Kouwenhoven et al., 2011; Williams et al., 2011).
It’s estimated that depression has a prevalence of 5.4 to 8.9 percent in the United
States general population, subsequently affecting 5 to 13 percent of patients in the
primary care setting (Maurer & Darnall, 2012). Depression is attributed to $43 billion in
medical care and costs (Maurer & Darnall, 2012). While depression can be present in the
absence of other conditions, there is a higher incidence of depression in the presence of
other conditions such as chronic medical illness, chronic minor daily stress, chronic pain
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syndrome, family history of depression, female sex, low income job/loss, low selfesteem, low social support, prior history of depression, single/divorced/widowed,
traumatic brain injury, and younger age (Maurer & Darnall, 2012). Depression has been
associated with increased mortality, worsening preexisting conditions such as
cardiovascular disease and diabetes, can lead to suicide (Hollender, 2014).
Stroke is a common medical condition, with over 600,000 new cases annually
(Whyte & Muslant, 2002; American Heart Association, 2015). In the United States, there
are 4.5 million survivors, however this figure is projected to increase as the management
of stroke continues to improve (Whyte & Muslant, 2002; American Heart Association,
2015). Stroke results in changes in an individual’s life, there can be a significant amount
of loss related to health, occupation, social role and independence. Subsequently major
depression is a common occurrence after a stroke. Approximately one third of stroke
victims will suffer from post stroke depression with a peak prevalence within the first
year (American Heart Association Stroke Council, 2017). Post stroke depression is
thought to complicate and delay stroke rehabilitation, subsequently leading to poorer
outcomes (Kouwenhoven, Kirkevold, Engedal, & Kim, 2011).
Kirkil, Deveci, Deveci, and Atmaca (2015) conducted a cross sectional study to
investigate the prevalence and relationship of depression in chronic obstructive
pulmonary disease patients (COPD). The investigators enrolled 80 COPD patients in the
study. The results of the study showed that depression was diagnosed in 42 (52.5%) of
the patients using the Beck Depression Inventory and 51 (63.8%) using the Hospital
Anxiety and Depression Scale (Kirkil, Deveci, Deveci, & Atmaca, 2015). In addition to
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identification of depression in COPD patients, the authors linked the depression
symptoms exhibited to the stage of the disease. Results demonstrated the more advanced
the stage of COPD, the greater the depressive symptoms. Depressed mood in COPD
patients were linked to poorer outcomes (Kirkil et al., 2015).
In a similar study, investigating the effect of anxiety and depression on self-care
agency and quality of life the results demonstrated a correlation between depressive
symptoms, self-care and quality of life in COPD (Yildirim, Asilar, Bakar, & Demir,
2013). Yildirim, Asilar, Bakar, and Demir (2013) completed a study in Turkey evaluating
the effects of COPD. The descriptive study had 135 hospitalized patients from January to
June 2010, who met the inclusion criteria. The results yielded 85.6% of patients at risk
for depression and 69.6% at risk for anxiety (Yildirim, Asilar, Bakar, & Demir, 2013).
Self-care scores and quality of life had a negative correlation to the risk of depression and
anxiety, meaning the lower the self-care score the lower the quality of life, while there
was an increased risk of depression and anxiety (Yildirim et al., 2013). The conclusion of
the study stated anxiety and depression have a disruptive impact of physical,
psychological and social functioning, as well as an undesirable effect on treatment
compliance and recovery (Yildrim, Asilar, Bakar, & Demir, 2013).
Kouwenhoven et. al (2012) performed a qualitative study to describe the “lived
experience” of stroke survivors with depressive symptoms in the acute phase of a stroke.
The study consisted of nine participants in stroke and rehabilitation units in Norway,
meeting the inclusion criteria. Participants engaged in 45 to 90 - minute interview
sessions with the investigators occurring 4 and 7 weeks following the stroke. Two main
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themes were generated from the study including feelings of being trapped and losing
oneself. The authors stated that three of the participants referred to their feelings as
depression, two as not depressed, and four made no reference to the term at all, however
all had a score suggestive of depression according to the Beck Depression Scale
(Kouwenhoven et al., 2012). Stroke survivors may not refer to the emotions as depressive
symptoms, but describe them in relation to losses, despair and grief and these symptoms
may not be viewed as clinical depression by healthcare providers (Kouwenhoven et al.,
2012).
Robinson-Smith et al., (2000) conducted a longitudinal correlational descriptive
design study investigating self-care, self-efficacy, quality of life and depression after
stroke. Participants were identified by records of admission to three hospitals inside a key
rehabilitation institution in northeastern United States. The purpose of the study was to
determine the relationship of self-care, self-efficacy to functional independence, quality
of life and depression after a stroke at one and six months. At the one - month time
period, the study had 77 participants, however 14 did not participate at six months for
assorted reasons, such as death, mental status change below target, relocation, spouse
illness, and refusal (Robinson-Smith et al., 2000). Overall there were 63 participants
included in both the one month and six-month interval. The results demonstrated lower
rankings in independence and health, lack of job, sex life and personal control and lack of
job and sex life at one month and six months respectively (Robinson-Smith et al., 2000).
Additionally, in the six-month quality of life assessment participants reported lower
quality of life regarding travel on vacation, pursuit of leisure activities, amount of stress
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or worries, and the potential to have a long life. Symptomatic depression was identified in
25% of the participants at one month, conversely at six months’ depressive symptoms
were identified in 15% of the participants. In the one - month time frame, functional
independence did not demonstrate a relationship to quality of life, however it did
demonstrate a strong relationship to depression. According to the authors one month after
a stroke, self-care and self-efficacy contributed to 51% of the variance in depression and
coping 52% in quality of life. The authors reported statistically significant differences
between one month and six months after stroke in the categories of self-care, selfefficacy, quality of life and depression with a 95% confidence level. Robinson-Smith,
Johnston, and Allen (2000), concluded that self-care, self-efficacy is related to quality of
life and depression after stroke.
Haung et al., (2014) conducted a study exploring factors associated with
depression in older residents with stroke in long-term care facilities. The cross-sectional
design spanned twenty-three institutions in southern Taiwan. The authors utilized
purposive sampling, enrolling 111 participants that met criteria. The participants were
screened for depression using the Taiwan Geriatric Depression Scale (TGDS). The
authors reported 41 of the 111 participants experienced depression, 36.9% of the total
group (Huang et al., 2014). Prevalence of depression was 45.7% in nursing homes, 36.2%
in intermediate care facilities, and 22.2% in domiciliary care facilities, with low Barthel’s
Index scores correlated to more depressive symptoms (Huang et al., 2014). The
recommendation of the authors was depression screening for elderly residents with stroke
on admission to long-term care facilities by the healthcare provider (Huang et al., 2014).
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Joubert et al., (2006) performed a prospective randomized control trial in a stroke
unit. Participants of the study were randomized to an intervention or control group and
were followed over a 12-month period. The purpose of the study was to evaluate the
effect of a shared care model on management of vascular risk factors for stroke according
to approved best practice guidelines, effect of screening for post stroke depression by a
validated telephone assessment method with feedback to the General Practitioner (GP).
Additionally, in the context of a shared model, what is the effect of such a shared care
model on stroke recurrence and long-term stroke related mortality? A total of 80 patients
were randomized into the study, with 35 in the control and 45 in the intervention group
(Joubert et al., 2006). Overall the researchers reported better management of risk factors
in the intervention group when compared to the control group. In specific regards to
depression approximately 45% of the control group screened as depressed at 12 months,
compared with 20% of the intervention group that screened as depressed (Joubert et al.,
2006).
Williams et al., (2011) conducted a quasi-experimental study. The purpose of the
study was to assess pre-post change in depression screening and treatment using an
electronic medical record-based system intervention in veteran ischemic stroke survivors
receiving care at two VA Medical Centers over a four-year period. The study included
652 participants, 278 veterans in the intervention group and 374 veterans in the control
group. The authors reported post stroke depression screening was performed within six
months for 85% of the intervention group compared with 50% of the control group, and
the treatment action was received by 83% of the intervention group compared with 73%
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of the control group who screened positive for depression (Williams et al., 2011). The
authors concluded that automated depression screening in primary and specialty care can
improve detection and treatment of post stroke depression.
Lightbody et al., (2007) conducted a cross-sectional pilot study comparing clinical
diagnosis of depression by a psychiatrist with two clinical interviews, using the Geriatric
Mental State (GMS) exam and the Montgomery-Asberg Depression Rating Scale
(MADRS), performed by a nurse. The study had 28 participants. Lightbody et. al (2007)
reported the psychiatric clinical diagnosis (PCD) classified 25% of the patients as
depressed, the MADRS and GMS classified 43% and 54% patients respectively as
depressed. The PCD was performed by the psychiatrist while the MADRS and GMS was
performed by nurses. The investigators further reported that when compared to the PCD,
the GMS had a sensitivity of 71% (CI 29-96%), specificity of 67% (CI 43-85%), positive
predictive value of 42% (CI 15-72%) and a negative predictive value of 88% (CI 6298%) (Lightbody et al., 2007). The overall efficiency of the GMS was 68% (CI 48-84%)
(Lightbody et al., 2007). The MADRS had a sensitivity of 100% (CI 59-100%),
specificity of 65% (CI 38-86%), positive predictive value of 54% (CI 25-81%) and
negative predictive value of 100% (CI 72-100%), with an overall efficacy of 75% (CI 5390%) (Lightbody et al., 2007). Lightbody et al., (2007) concluded that nurses have an
instrumental role in detecting, preventing, and managing the depression in the post stroke
patient.
McIntosh (2017) completed an evidence-based quality improvement project, a
depression screening protocol in patients with acute stroke. The purpose of the quality
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improvement project was to determine efficacy of an evidence-based depression
screening protocol in early detection and treatment of post stroke depression and to
identify any relationships between the protocol interventions, depression scores, and
diagnosis (McIntosh, 2017). In the project nurses completed depression screening
utilizing a validated tool on patients that had a confirmed diagnosis of stroke. The study
used a convenience sample of 79 hospitalized patients with acute stroke (McIntosh,
2017). Results yielded 48% of the participants were identified as being depressed as
defined by a score >4 on the validated tool, patient health questionnaire 9 (PHQ-9).
Additionally, patients who had positive depression screening were more likely to receive
education on stroke and depression, in conjunction with being medically treated for
depression before discharge (McIntosh, 2017). The project also demonstrated an increase
in nurse’s documentation of screening results, (x2=9.19, p=.002). Mcintosh (2017)
concluded that an evidence-based depression screening protocol improved early detection
and treatment of post stroke depression in hospitalized patients in the acute care setting.
Melrose (2016) wrote an article centered on the nursing role in identification of
post stroke depression. Post stroke depression has been associated with poor recovery and
rehabilitation response, reduced social interactions, increase utilization of healthcare
services, increased rates of cardiac and stroke sequalae, and increased mortality rates
(Melrose, 2016). Melorose (2016) stated recognizing and responding to depression is a
priority for nurses and formal caregivers knowing prevalence of post stroke depression is
10% - 50% in stroke survivors. Post stroke depression can have extended durations, for
several years if not treated (Melrose, 2016). Scales and questionnaires are valuable
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resources that can aid a nurse in the assessment of post stroke depression (Melrose,
2016).
Screening for post stroke depression has historically been considered a condition
associated with primary care, not in the acute care (hospitalized) setting. However acute
care settings have implemented various processes to address depression screening, as a
response to the previous Joint Commission Disease Specific Certification (L. Durm,
personal communication, September 18, 2017).
The goal of the DNP project was to develop a clinical practice guideline for post
stroke depression screening. The desired impact of the clinical practice guideline was to
provide a standard and process for depression screening in the post stroke patient.
Local Background and Context
Depression is a condition with high prevalence worldwide. Depression includes
disorders of major depression, minor depression and dysthymia. Depression affects
approximately 340 million people worldwide, with 18 million people suffering from
depression in the United States (Egede & Ellis, 2010). Egede and Ellis (2010) reported
that according to the World Health Organization depression is accountable for the highest
proportion of burdens associated with non-fatal health outcomes accounting for
approximately 12% total years lived with disability. Studies (Andersen et al., 2000;
Kouwenhoven, Kirkevold, Engedal, & Kim, 2011; Williams et al., 2011) have
demonstrated that depression is a major cause of morbidity, mortality and increased use
of healthcare resources.
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It’s estimated that depression has a prevalence of 5.4 to 8.9 percent in the United
States general population, subsequently affecting 5 to 13 percent of patients in the
primary care setting (Maurer & Darnall, 2012). Depression is attributed to $43 billion in
medical care and costs (Maurer & Darnall, 2012). While depression can be present in the
absence of other conditions, there are some that have a higher incidence of depression
such as chronic medical illness, chronic minor daily stress, chronic pain syndrome,
family history of depression, female sex, low income job/loss, low self-esteem, low social
support, prior history of depression, single/divorced/widowed, traumatic brain injury, and
younger age (Maurer & Darnall, 2012). Increased mortality, worsening preexisting
conditions such as cardiovascular disease and diabetes, can lead to suicide (Hollender,
2014).
Stroke is a common medical condition, with over 600,000 new cases annually
(Whyte & Muslant, 2002; American Heart Association, 2015). In the United States, there
are 4.5 million survivors, however this figure is projected to increase as the management
of stroke continues to improve (Whyte & Muslant, 2002; American Heart Association,
2015). Stroke results in changes in an individual’s life, there can be a significant number
of losses related to health, occupation, social role and independence. Subsequently major
depression is a common occurrence after a stroke. Approximately one third of stroke
victims will suffer from post stroke depression with a peak prevalence within the first
year (American Heart Association Stroke Council, 2017). Post stroke depression is
thought to complicate and delay stroke rehabilitation, subsequently leading to poorer
outcomes (Kouwenhoven, Kirkevold, Engedal, & Kim, 2011). Despite the prevalence of
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post stroke depression and recommendations for screening, there remains a lack of
clinical practice guidelines to facilitate the process and standardization of care.
The project setting was located within a healthcare system in the southern United
States. The healthcare system is comprised of 11 hospitals, 15 urgent care centers, 16
satellite diagnostic imaging centers, three health parks and a pediatric center, one adult
congregate living facility, three skilled nursing facility, and three inpatient hospices. The
organizations are either Primary Stroke Center Certified or Comprehensive Stroke Center
Certified as designated by the Joint Commission, the differences were discussed earlier in
the project. As with any other organization, the project setting has a mission and vision.
The mission is to create and deliver high quality hospital, physician and other healthcare
related services that improve the health and well-being of the individuals and
communities it serves. In conjunction with the mission, the vision of the organization is
to deliver world-class healthcare.
Role of the DNP Student
The DNP project was a fulfillment requirement of Walden University, as such the
student was the leader of the project. The DNP project leader was responsible for the
primary authorship of the proposal, project design and implementation, data analysis, and
summarization. Factors considered when choosing a focus for the DNP project was the
patient population in my professional practice and the practices between various entities
within the same healthcare system. Another influencing factor to the DNP project topic is
being a Clinical Nurse Specialist (CNS). A CNS is a Master’s or Doctoral prepared
Advanced Practice Nurse whose primary function is to improve outcomes in patient care.
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The CNS has expertise in clinical practice, patient education, research and consultation to
impact the three spheres of influence: patient care, nursing and systems (Sparacino &
Cartwright, 2009). As the CNS in neurosciences, there is a constant monitoring of clinical
practice in addition to staying abreast of evidence and/or guidelines of
regulatory/authority bodies. In the recent American Heart Association/American Stroke
Association (AHA/ASA) guidelines there is a recommendation that post stroke patients
be screened for depression (Powers et al., 2018). However, the guidelines do not specify
if depression screening is recommended in the stroke patient receiving care at a
comprehensive stroke center or primary stroke center as part of the acute management
phase. Therefore, the inference is that all post stroke patients regardless of the stroke
center designation should be screened. Development of clinical practice guidelines for
depression screening will improve standardization, consistency, and care in poststroke
patients across the healthcare system rather than just a single entity.
Summary
The review of the literature has supported that screening for depression in post
stroke patients can improve early identification and treatment in that population. The
utilization of an evidence-based tool related to depression screening in the post stroke
patient will improve quality of life, self-care, self-efficacy and functional outcomes.
However, without a clinical guideline there is a decreased likelihood that depression
screening will occur. Section 2 of this project presented an overview of stroke and the
connection to depression, John Hopkins Evidence-Based practice model as the
framework, and the role of the DNP student in carrying out the evidence-based project.
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Section 3 discussed the literature search of depression, depression screening and the
approach to the DNP project.
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Section 3: Collection and Analysis of Evidence
Introduction
The purpose of this project was to develop a clinical practice guideline for
depression screening in poststroke patients. The overall goal of this project was to
develop a clinical practice guideline for depression screening, which will ultimately
facilitate early identification and treatment if warranted in post stroke patients.
Section 3 outlines the development process of the project. This section reviews
the practice-focused question, sources of evidence reviewed regarding the topics of
depression and depression screening, the project’s approach, population/sampling, data
collection, data analysis, project evaluation, and summary.
Practice-Focused Question
The local problem that the DNP project addressed is the lack of depression
screening in poststroke patients. The following practice-focused question guided my
project: What are current evidence-based approaches for screening for depression in the
post stroke patient? The goal of this project was the development of a clinical practice
guideline for depression screening in a primary stroke center to screen for depressive
symptoms in poststroke patients. After the conclusion of development of the clinical
practice guideline, the outcomes included the following:
Outcome 1: Literature Review Matrix: Depression screening in patients with
chronic conditions with comprehensive review of the literature
Outcome 2: Development of a clinical practice guideline for post stroke patients
with a validated tool
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Outcome 3: Approved clinical practice guideline by an expert panel for
depression screening in post stroke patients
The summation of outcomes and dissemination to program stroke coordinator and
other stakeholders will occur after graduation from Walden University.
The following terms were used in developing the project:
Clinical guidelines: Standardized current national and international guidelines for
the assessment, diagnosis, and management of patient conditions that are developed by
clinical guideline panels or professional groups to improve the outcomes of care and
promote evidence-based health care (Grove, Burns, & Gray, 2013).
Protocol: A detailed plan of scientific or medical experiment, treatment or
procedure (Merriam-Webster, n.d.).
Poststroke depression: The onset of persistent sadness or loss of interest in the
acute phase of a stroke, a time span from 2 weeks up to 1 year following a stroke (Buga
et al., 2015).
Sources of Evidence
The sources that were used for the review were recent evidence-based projects
and peer-reviewed literature. To facilitate development of the clinical practice guideline,
I used the current clinical guidelines from the American Heart/Stroke Association, the
UPTSF, and other evidence-based guidelines. Information was used to define depression
and onset of depression in poststroke patients, and identify validated assessment tools,
treatment recommendations, and follow up which will be included in the clinical practice
guideline. These sources are currently used to define some aspects of care in the stroke
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patient within the organization. Incorporating them into the clinical practice guideline
provided additional support for implementation in the organization. Collecting and
analyzing this evidence was imperative to discovery of evidence-based approaches to
depression screening in post stroke patients for cumulation into a clinical practice
guideline.
Published Outcomes and Research
I performed a literature review for the most current and relevant information
related to this project, which is depression screening in poststroke patients. The following
electronic databases were utilized: The Cumulative Index to Nursing and Allied Health
Literature, Cochrane Database of Systematic Reviews, Cochrane Central Register of
Controlled Trials, Cochrane Methodology Register, and PsycARTICLES. The keywords
that were used to retrieve sources of evidence included: depression and post stroke,
depression screening, depression screening tools, post stroke, evidence based-guidelines
and protocols, and John Hopkins Evidenced-Based Practice Model. The search was
limited to articles from 2000 to 2016 which were relevant to the project.
Evidence Generated for the Doctoral Project
Participants
Once the clinical practice guideline was developed, an expert panel was formed.
Qualifications for an individual to be considered for the panel was contingent on practice
specialty or job functions, such as neurologist or stroke program director respectively.
The expert panel was limited to a maximum of five participants. The second panel
consisted of the potential end users of the clinical practice guideline, bedside clinician,
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stroke program coordinator, a clinical nurse specialist, and unit director. It is important
that the end user was engaged in the review of the guideline as to ensure usability. All
participants were contacted via email for participation.
Procedures
The initial step for developing a clinical practice guideline was the identification
of the problem the guideline will address. As previously discussed, the practice problem I
observed was the lack of depression screening in poststroke patients at the project site.
The practice question developed is what are current evidence-based approaches for
screening for depression in the poststroke patient? I developed evidence selection criteria
for the clinical practice guideline. Selection criteria used any previously published
guidelines or recommendations regarding depression screening and depression screening
in the poststroke population. Other pertinent selection criteria were evidence that
contained adults, ages 18 and older, stroke survivors, and inpatient care settings and
depression tool. The selection criteria were organized in a chart using Microsoft Word
(Appendix A). The evidence included peer-reviewed, original research studies and
evidence-based projects. The evidence was evaluated for the selection criteria; however,
the evidence was not to be eliminated if all criteria are not met. Importance was placed on
setting, population age, and depression screening tool. For evidence missing elements of
the selection criteria, the level of evidence was of heavier significance. I used a letter
coding system to describe the feedback received from the expert panelists. The evidence
was appraised using the JHNEBP levels of evidence. Following the appraisal of the
evidence, it was synthesized and used to develop the clinical practice guideline. Once the
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clinical guideline was developed, the expert panelist was contacted via email with the
link to the feedback form. The feedback from the expert panelist was collected using the
standard instrument, the AGREE II. AGREE II is a 23-item instrument (Appendix D) that
is divided into six quality domains with a 7- point Likert scale to score each item that was
used to collect recommendations from the expert panelist (AGREE Next Steps
Consortium, 2013). The Likert scale has a range of 1 to 7, with 1 meaning strongly
disagree and 7 meaning strongly agree. AGREE II has an acceptable reliability in most
domains with Cronbach’s alpha 0.64-0.88 with 95% of appraisers finding the tool useful
for evaluating guidelines (Brouwers et al., 2010). The panelist was sent an electronic link
via email to the standard instrument. This facilitated anonymity of the panelist. All
information was stored in a secured location with access restricted to me. I retrieved the
feedback from the AGREE II website and scores of the clinical practice guideline. After
the revisions were completed, the clinical practice guideline was submitted to the second
group to discuss content validation and usability. At the conclusion of the feedback from
the expert panelist and end-user/key stakeholders, a final report of the clinical practice
guideline will be developed and disseminated.
Protections
I collaborated with the clinical site mentor to identify panelist for the project.
Once identified panelist were contacted in the manner previously described. To protect
each panelist identity, each participant was emailed the identical communication
separately, there were no group email communication. Email communications were saved
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to a password protected folder. Absence of feedback within the AGREE II instrument
was considered as voluntary withdrawal from the project.
Once I obtained committee approval, the project was submitted to the
University’s IRB review for approval. The University’s IRB role was to review the
project for any potential human subject violations or any breaches in data collection in
accordance to institutional regulations. Following the approval from University IRB, the
project was submitted to the project site’s IRB for review and approval. The role of the
project site’s IRB was to ensure the project complies with the organization’s research
requirements and human subject protection.
An ethical dilemma I navigated is bias. Bias means to slant away from the true or
expected (Grove et al., 2013, p. 197). Due to the time spent researching the evidence, I
had developed a belief the depression screening in poststroke patients should be part of
the management phase in the acute care setting. To mitigate the bias to depression
screening, the I used the recommendations from the expert panel to support use of the
clinical practice guideline.
Analysis and Synthesis
Approach
The Appraisal of Guidelines Research and Evaluation (AGREE) II was used to
develop the clinical practice guideline. This project targeted hospital patients admitted to
an acute care stroke unit in a primary stroke certified designated hospital. I obtained IRB
approval, 01-09-19-0558331 from the University and the project site (see Appendix B).
Permission was also obtained from leadership at the project site prior to implementation.
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I developed clinical practice guidelines based on current evidence. Once the clinical
practice guideline was developed, I sought out panelist to participate on the expert panel
to provide feedback and recommendations. Panelist considered were relevant
professionals such as a mental health provider, neurology provider, and an advanced
practice nurse, such as a clinical nurse specialist. Potential panelists were contacted via
email to serve as participants using the University’s approved disclosure to expert
panelist form for anonymous questionnaires (see Appendix C). Participation was
voluntary. Panelist were sent the AGREE II instrument and a link to the electronic
guideline to review. Once the AGREE instrument was returned by the expert panel, I
revised the clinical practice guideline according to the received recommendations. The
next step was to identify a group of key stakeholders including neuroscience nurses,
stroke program coordinator, clinical nurse specialist to present the revised guideline to for
validation and usability. To identify the key stakeholders, I used the host facility
organizational chart in addition to the administration list. Final feedback from end users
will be compiled in a report that will be disseminated to key stakeholders.
Data Analysis
Data analysis was conducted using the AGREE II score calculator (Appendix E).
I analyzed each of the six domain scores and overall assessment of the clinical practice
guideline. Overall score for recommendation to use clinical practice guideline was
reported.
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Evaluation
At the completion of the EBP project a summative evaluation was conducted. The
summary consisted of the individual appraisers scoring and overall assessment of the
clinical practice guideline. Recommendations for use was also included in the summative
evaluation. The evaluation will be presented to the stakeholders of the organization
following conferral of the student’s doctorate degree.
Summary
Section 3 provided a review of the DNP project, detailed overview of method of
the literature search using the key terms depression and stroke, evidence-based guidelines
and protocol and depression, depression screening, depression screening tools, depression
screening. The methodology of the DNP project was also discussed in this section.
Section four will discuss the findings, implications, recommendations, strength and
limitations of the clinical practice guidelines.
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Section 4: Findings and Recommendations
Introduction
Depression poststroke affects approximately one third of stroke survivors
(American Heart Association Stroke Council, 2017). Depression has been demonstrated
to have a significant impact on the quality of life, functional recovery, morbidity, and
mortality of the poststroke patient (Robinson-Smith et al., 2000, Yildirim et al., 2013).
Powers et al. (2018), on behalf of the American Heart/Stroke Association, made
recommendation for depression screening for poststroke patients in the 2018 Guidelines
for the Early Management of Patients with Acute Ischemic stroke. Despite this
recommendation, there is a lack of guidance on which validated tools to use, address
optimal timing for screening, and appropriate healthcare personnel to perform the
depression screening in the poststroke patient.
The DNP project site, a multicenter healthcare system located in the southern
United States, used the guidelines of the American Heart/Stroke Association (see Powers
et al., 2018) in addition to standards of care of The Joint Commission (see The Joint
Commission, 2018) in the delivery of care of the stroke patient. However, the
organization lacks mechanisms and or processes in place to perform depression screening
in poststroke patients. The DNP project sought out to address this gap in practice. The
goal of this project was the development of a clinical practice guideline for depression
screening in a primary stroke center to screen for depressive symptoms in poststroke
patients.
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As mentioned earlier in this paper, the sources that were used for the review were
recent evidence-based projects and peer-reviewed literature. I used current clinical
guidelines from the American Heart/Stroke Association, the UPTSF, and other evidencebased guidelines. Information from sources were used to define depression and the onset
of depression in poststroke patients, and to identify validated assessment tools, treatment
recommendations, and follow-up, which will be included in the clinical practice
guideline. The sources of evidence were then appraised using the JHNEBP research
appraisal method, reflected in Appendix A. The evidence from the sources were then
synthesized to develop the clinical practice guidelines (Appendix F).
Findings and Implications
The project was carried out as specified in the procedure. Five individuals from
the project site were invited to participate on the expert panel. Four panelists completed
feedback using the AGREE II instrument. Participation was voluntary, lack of response
from the fifth panelist was assumed as a withdrawal of participation. The AGREE II
instrument uses a Likert scale scoring 1-7 that the expert panelist used to rank items in
each domain (Table 1).
A quality score was then calculated for each domain. There are various methods
on which domains are highest priority, depending on the preference of the users. For the
intent of this DNP project, all domains are of equal significance, therefore all domains
have a calculated quality score. Threshold for the quality score is 70%, which means
quality scores 70% or higher signify a high-quality guideline. The quality scores for each
domain are Domain 1 Scope and Purpose: 89%, Domain 2 Stakeholder Involvement:
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68%, Domain 3 Rigor and Development: 72%, Domain 4 Clarity of Presentation: 93%,
Domain 5 Applicability: 71%, and Domain 6 Editorial Independence: 81%. The overall
assessment of the clinical practice guidelines was 79%, which indicated high quality
guidelines based on the ratings of the expert panel. Although the overall assessment
revealed a high-quality clinical practice guideline, there are opportunities for revisions in
three of the domains: stakeholder involvement, rigor and development, and applicability
with quality scores of 68%, 72% and 71% respectively. The expert panelists were also
asked to provide an additional overall assessment and recommendation for use of the
clinical practice guidelines. For the final category there is not a quality score applied as
with each domain, but rather it is reported as a raw score based on the number of
panelists that responded yes, yes with modifications, or no for recommendation for use of
the clinical practice guidelines. All panelists responded yes to a recommendation for use,
however one (25%) panelist responded “yes” and three (75%) responded “yes with
modifications”. None of the panelist responded “no”.
An unanticipated limitation of the DNP project were challenges in obtaining
feedback from the second panel of end users prior to the conclusion of the
implementation phase. Multiple attempts were made but I was unsuccessful in obtaining
meeting times from identified participants of the second group due to scheduling conflicts
and organizational priorities such Joint Commission survey visits and disaster drills. This
limitation delayed providing the summation report for the leaders in the organization as
well as vetting the usability with the end users.
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Another limitation was the lack of narrative comments or feedback from the
expert panelists when rating scores were low on the Likert scale, (below 5). This lack of
feedback prohibited me from specifically addressing the deficit. Although there was
strong support recommending the guidelines for use with modifications, limitations on
revisions exist around the lack of details of required modifications.
The response rate of the expert panelist is another limitation. As stated previously,
five experts were contacted via email to participate in the expert panel. However, only
four of the five completed the instrument. The panelist who did not complete the AGREE
II instrument on the clinical practice guidelines served in the role as a neurologist. The
lack of feedback from a medical doctor affects the willingness of leaders of the
organization to implement the practice guidelines.
The clinical practice guideline lacked treatment options for those who were
identified to have depressive symptoms, which is a limitation of the project. This area
was excluded from the clinical practice guideline because it would significantly lengthen
the guidelines which had the potential to impact expert panelist participation.
Potential implications include depression screening in poststroke patients within
the project site using the clinical practice guidelines. The incorporation of the clinical
practice guidelines in the clinical setting would provide standards on timing of depression
screening, frequency intervals, who should perform the screening, and what tools to
utilize for depression screening. Admitted stroke patients would receive the standard of
care as recommended by the American Heart/Stroke Association, promoting early
identification and ultimately treatment. Another implication within the organization is the

41
increased engagement from nursing in proactively assessing for signs of depression
through performance of depression screening. Additionally, patients and caregivers
would have increased awareness lessening the negative stigma around depression. For
healthcare systems such as the project site, implementation of depression screening
clinical practice guidelines increases standardization across the system. It also improves
communication with community providers. Additionally, upon discharge overall
effectiveness is achieved improving the assessment and management of depression in the
poststroke patient.
An outcome of doctorate education is the ability to influence positive social
change. The successful implementation of the clinical practice guideline has the potential
to expand beyond the project site. Through dissemination at conferences, forming
collaborative relationships with other colleagues on the subject of depression will
facilitate the ultimate goal of developing the DNP project clinical practice guidelines into
national practice guidelines. Development and implementation of national practice
guidelines for depression screening poststroke will eliminate the ambiguity surrounding
timing, screening tools, who performs depression screening, management and treatment
for those patients who screen positive for depression and providing organizations to
enhance care delivered to poststroke patients. This enhanced care has the potential to
improve the quality of life, mortality, and morbidity of the stroke survivor.
Recommendations
Although the clinical practice guidelines were developed as a part of the DNP
project, I received a strong recommendation for use by the expert panelist. Additionally,
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feedback from the end users will be a critical component of successful implementation.
The clinical practice guidelines will need revisions based on the recommendations prior
to sharing with end users. Once end user feedback is obtained, future solutions include
implementation of the clinical practice guidelines with a pilot study. Implementation of
the guidelines will need to be supported with educational in services and training
regarding depression screening as this will be a change in current practice. Those aspects
were not included as part of the DNP project and will need to be developed.
Strengths and Limitations of the Project
The DNP project, development of clinical practice guidelines for depression
screening poststroke has mentionable strengths. The response rate of the expert panelist,
80% yielded a high-quality review of the clinical guidelines. The high ratings, in
conjunction with a recommendation for use with modifications is another identified
strength. Limitations of the project include absence of feedback from a neurologist, end
user feedback, and absence to improve guidelines because of missing comments or
details.
Recommendations for future projects would be to revise guidelines according to
suggestions of the expert panel. An additional recommendation is to collaborate with the
panel to ensure the inclusion of treatment options into clinical practice guidelines. The
clinical practice guidelines provide guidance surrounding depression screening in
poststroke patients; however, evaluation of actual impact should be considered in future
projects.
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Table 1
Expert Panelist Ratings
Domain
Domain 1: Scope
and Purpose
Item 1
Item 2
Item 3
Domain 2:
Stakeholder
involvement
Item 4
Item 5
Item 6
Domain 3: Rigor
of Development
Item 7
Item 8
Item 9
Item 10
Item 11
Item 12
Item 13
Item 14
Domain 4:
Clarity of
Presentation
Item 15
Item16
Item 17
Domain 5:
Applicability
Item 18
Item 19
Item 20
Item 21
Domain 6:
Editorial
Independence
Item 22
Item 23
Overall
Assessment

Appraiser 1

Appraiser 2

Appraiser 3

Appraiser 4

7
6
7

6
6
7

7
6
7

6
5
6

7
7
7

4
3
7

7
7
7

3
1
1

7
7
6
7
7
7
7
6

6
1
4
4
6
5
5
1

6
6
3
2
6
6
4
6

6
5
6
6
6
6
7
3

7
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Section 5: Dissemination Plan
As mentioned in an earlier part of this paper, the project will be disseminated to
the stakeholders of the organization in a report after graduation. This report will include
the expert panel ratings and recommendation, as well as the end user feedback. Future
attempts will be made to coordinate with the end user group to obtain feedback,
following completion of the DNP program.
The summation report will be shared with the stroke program directors, medical
directors, and organization accreditation specialists. Subsequent dissemination to the
larger leadership team and nursing practice councils will be necessary for full support of
the clinical practice guidelines.
In consideration of advancement to the nursing profession, dissemination of the
clinical practice guidelines is recommended to the local and or regional stroke alliance
organizations. Secondly, dissemination should occur at national and stroke-related
conferences. Magnet conferences would be a third venue as those are heavily focused on
the impact nurses have on the outcomes of patients. The ultimate venue would be at the
International Stroke Conference, which occurs annually at various locations within the
United States.
Analysis of Self
The DNP project has provided me with many opportunities to function in
different capacities. One role is that of practitioner. I am a clinical nurse specialist, which
is a form of a practitioner. In this role, I constantly must investigate strategies to improve
the health of the stroke population and the best ways to incorporate those strategies into
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clinical practice. The scholar role challenged me throughout the DNP project in finding
relevant sources and critically appraising the evidence. Prior to initiation of the DNP
project, I identified as being a novice scholar, however by the conclusion of the project, I
feel I have progressed to being competent. As project manager, I designed the project,
projected a timeline, “engaged in selling” the concept, implemented the project, obtained
and analyzed findings, and concluded with a report of the findings. Generally, a project
manager collaborates with a team of individuals and delegates different aspects of a
project; however, because I elected not to designate a team, I was accountable for all
aspects of the project. That degree of responsibility required me to be organized, and use
calendars, trackers, and other available resources. All the roles have facilitated growth in
collaboration with members in other roles as well as other organizations, which I was not
accustomed to. Long term, I want to continue to advance development of clinical practice
guidelines for depression screening in poststroke patients through forming collaborative
relationships with other professionals involved with care and outcomes of the stroke
patient.
Throughout the project, I identified areas of growth opportunities. A significant
lesson I learned is to always identify key stakeholders and involve them in the initial
planning stages, including the development of the idea. Awareness of those key
individuals can have a significant impact on required approvals. Another opportunity was
formulating necessary relationships when partnering with other organizations. It is
important to comprehend the individual’s role within the organization and his/her
priorities. Although project site approval had been granted by the project site, I made
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several trips to meet with potential participants on the expert panel to obtain buy-in. A
final lesson I learned is to be accepting that the journey is not smooth. Obstacles will
happen that will impact the original plan of the project such as unforeseen challenges in
scheduling conflicts that prevent the group from meeting as initially planned. However,
the project must come to an end, therefore said barriers become a limitation. It is not the
end, but just a detour in the journey to improve patient care while simultaneously
impacted the nursing profession.
Summary
Stroke is the fifth leading cause of death in the United States but remains the
leading cause of disability (American Heart Association, 2015). This population of
individuals, the poststroke patient, has a higher propensity of developing depression
poststroke (American Heart Association Stroke Council, 2017). Depression poststroke
can have a negative impact on the quality of life and increase mortality and morbidity of
the stroke survivor (Buga et al., 2015, Kouwenhoven et al., 2011, Robinson-Smith et al.,
2000). Despite the prevalence of depression poststroke in the evidence and
recommendations for screening, there lacks clinical practice guidelines for depression
screening of the poststroke patient. The aim of this DNP project was to address the gap in
practice through development of clinical practice guidelines for depression screening
poststroke.
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